Last reviewed · How we verify
IPV ID Needle
IPV ID Needle is an intradermal delivery device designed to administer inactivated polio vaccine (IPV) using a micro-needle approach for improved immunogenicity and patient compliance.
IPV ID Needle is an intradermal delivery device designed to administer inactivated polio vaccine (IPV) using a micro-needle approach for improved immunogenicity and patient compliance. Used for Poliomyelitis prevention (intradermal administration of IPV).
At a glance
| Generic name | IPV ID Needle |
|---|---|
| Also known as | Inactivated Poliovirus Vaccine Intradermal using syringe and needle pair |
| Sponsor | London School of Hygiene and Tropical Medicine |
| Drug class | Vaccine delivery device |
| Modality | Small molecule |
| Therapeutic area | Immunology / Infectious Disease |
| Phase | FDA-approved |
Mechanism of action
The device delivers IPV intradermally rather than intramuscularly, targeting the rich immune cell populations in the skin to potentially enhance immune response while reducing vaccine volume requirements. This needle-based intradermal approach aims to improve vaccination efficiency and reduce the overall antigen dose needed for protective immunity against poliovirus.
Approved indications
- Poliomyelitis prevention (intradermal administration of IPV)
Common side effects
- Local injection site reactions (erythema, induration)
- Pain at injection site
Key clinical trials
- A Campaign-based ID fIPV Administration Trial (NA)
- IPV Clinical Trial - The Gambia (PHASE4)
- ID Administration of fIPV Using Intradermal Adapters vs. BCG Syringe (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |